Symphony, Bruker sign supply contract for XRF taggant technology

NewsGuard 100/100 Score

After a one year cooperative development, Bruker Corporation and Symphony Environmental Ltd have signed a contract for the exclusive supply of Bruker's X-Ray Fluorescence (XRF) taggant technology to Symphony for the identification of pro-degradant, anti-microbial and anti-fungal additives in plastic. This multi-year agreement will give Symphony and their customers the ability to unambiguously determine that plastic contains the proper components to ensure that it will perform as intended. Bruker's patented technology is contained in a lightweight handheld XRF analyzer, which can be taken into the field to perform measurements at almost any location in the world.

The Symphony d2w pro-degradant improves the speed at which plastic packaging will degrade, and in combination with the Bruker XRF technology allows rapid proof that the pro-degradant is present, as required by law in many countries now, or that d2p anti-microbial additive is present. "We are pleased with this agreement, as it reflects the strength and effectiveness of our XRF taggant technology," said John Landefeld, Bruker Elemental Managing Director.

Symphony's CEO, Michael Laurier, stated: "We are pleased to add this portable technology - marketed by Symphony as "d2Detector®" to the service that we offer to brand-owners and law-enforcement agencies, who need to know instantly that plastic products have been correctly made and are not counterfeit. Standing behind the d2Detector are Symphony's specialist laboratories which offer free in-depth service to our customers."

Source:

 Symphony

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New vaccine promises broad protection against SARS-CoV-2 and other sarbecoviruses